Healthcare Providers and Services
Company Overview of The General Hospital Corporation
The General Hospital Corporation operates as a general hospital in Boston. It offers services in the areas of allergy and immunology, blood, cancer, circulatory, dermatology, digestive, heart, infectious diseases, kidneys, lung, obstetrics and gynecology, psychiatry, rheumatology, surgery, and urology; bones, muscles, and joints; brain, spine, and nervous system; endocrine, diabetes, and metabolism; and mouth, teeth, and face. The company also provides patient and family support services, such as billing and insurance, child care, emotional and support programs, executive health, international patient, medical interpreter, medical records, mind body medicine, nursing, nutrition, patient and ...
55 Fruit Street
Boston, MA 02114
Founded in 1811
Key Executives for The General Hospital Corporation
Chief of Dermatology Service, Director of Melanoma Program for Mgh Cancer Center and Director of Cutaneous Biology Research Center
Chairman of the Chiefs' Council
Chief of Molecular Biology
Compensation as of Fiscal Year 2015.
The General Hospital Corporation Key Developments
Heidelberg Engineering Enters into a Patent License Agreement with Massachusetts General Hospital in Boston
Aug 25 15
Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and follow-up patients with diseases of the posterior segment of the eye, such as age-related macular degeneration, diabetic retinopathy, or glaucoma. Swept-source OCT technology has specific characteristics which are ideal to acquire comprehensive information about a wide variety of properties of the anterior part of the eye, especially of patients who have to undergo cataract or refractive surgery.
Massachusetts General Hospital Announces Executive Changes
Aug 18 15
Maria J. Troulis, DDS, MSc, has been named chief of the Massachusetts General Hospital (MGH) Department of Oral and Maxillofacial Surgery (OMFS). She also will serve as the next Walter C. Guralnick Professor and chair of Oral and Maxillofacial Surgery at Harvard School of Dental Medicine (HSDM). These appointments became effective
Aug. 1. She completed her residencies at Royal Victoria Hospital and Montreal General Hospital before coming to the MGH as a clinical and research fellow in Pediatric Craniomaxillofacial Surgery in 1997. She has remained part of the MGH community ever since. Among her many roles, Troulis serves on the MGH Executive Committee on Teaching and Education, as well as the newly formed Graduate Medical Education Committee and is a member of the Partners Education Committee and its Subcommittee of Evaluation and Feedback. Troulis teaches at Harvard Medical School, HSDM and the Harvard-MIT Health, Sciences and Technology program. Since 2005, she has directed the Harvard-OMFS Residency Program and during the past decade has transformed it into one of the most preeminent programs in the country. Troulis succeeds Leonard B. Kaban, MD, DMD, who since 1994 has served as chief of OMFS at the MGH and as the Guralnick Professor and chair of OMFS at HSDM. Kaban will remain active in the clinic and lab.
Massachusetts General Hospital Appoints Maria J. Troulis as Chief of Oral and Maxillofacial Surgery
Aug 18 15
Maria J. Troulis, DDS, MSc, has been named chief of the Massachusetts General Hospital (MGH) Department of Oral and Maxillofacial Surgery (OMFS). She also will serve as the next Walter C. Guralnick Professor and chair of Oral and Maxillofacial Surgery at Harvard School of Dental Medicine (HSDM). These appointments became effective Aug. 1, 2015. Troulis earned her masters degree and doctorate of dental surgery from McGill University in Canada. She then completed her residencies at Royal Victoria Hospital and Montreal General Hospital before coming to the MGH as a clinical and research fellow in Pediatric Craniomaxillofacial Surgery in 1997. She has remained part of the MGH community ever since. During her career she has changed the face of clinical OMFS by pioneering the use of minimally invasive surgical techniques, both distraction osteogenesis and endoscopic procedures. Her work in this area has paved the way for what has become the rapidly growing use of minimally invasive alternatives for the reconstruction of the jaw. Troulis also refined the minimally invasive approach of endoscopic management of salivary duct stones, sparing many patients from invasive surgical procedures.
Similar Private Companies By Industry
Recent Private Companies Transactions